2097002-61-2 Usage
General Description
LOXO-195 is a chemical compound that is currently being studied for its potential as a targeted therapy for cancer. It is an inhibitor of the tropomyosin receptor kinase (TRK) family of proteins, which are known to play a role in the growth and spread of cancer cells. By inhibiting TRK proteins, LOXO-195 may be able to stop the abnormal cell growth and division that characterizes cancer. Early studies have shown promising results in certain types of cancer, including solid tumors and sarcomas, and it is being evaluated in clinical trials to determine its safety and effectiveness as a treatment for these diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 2097002-61-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,0,9,7,0,0 and 2 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2097002-61:
(9*2)+(8*0)+(7*9)+(6*7)+(5*0)+(4*0)+(3*2)+(2*6)+(1*1)=142
142 % 10 = 2
So 2097002-61-2 is a valid CAS Registry Number.
2097002-61-2Relevant articles and documents
FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR
-
, (2019/05/15)
The present application in some embodiments provides a pharmaceutical composition comprising Compound (1), and a compounding agent. Further provided herein are methods of making and methods of using the pharmaceutical compositions, for example, in the treatment of cancer.
